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Multiple genetic variants of CARD15/NOD2 have been
associated with susceptibility to Crohn’s disease and
Blau syndrome. NOD2 recognizes muramyl dipeptide
(MDP) derived from bacterial peptidoglycan (PGN), but
the molecular basis of recognition remains elusive. We
performed systematic mutational analysis to gain insights
into the function of NOD2 and molecular mechanisms of
disease susceptibility. Using an archive of 519 mutations
covering B50% of the amino-acid residues of NOD2, the
essential regulatory domains and specific residues of
NOD2 involved in recognition of MDP were identified.
The analysis revealed distinct roles for N-terminal and C-
terminal leucine-rich repeats (LRRs) in the modulation of
NOD2 activation and bacterial recognition. Within the C-
terminal LRRs, variable residues predicted to form the b-
strand/bturn structure were found to be essential for the
response to MDP. In addition, we analyzed NOD1, a NOD2-
related protein, revealing conserved and nonconserved
amino-acid residues involved in PGN recognition. These
results provide new insights into the molecular function
and regulation of NOD2 and related NOD family proteins.
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Introduction
The susceptibility to genetic diseases is largely dependent
on the physiological consequence of genetic alterations. In
certain disorders including neurofibromatosis and Crohn’s
disease (CD), the genetic alteration involves highly mutated
disease-associated proteins (Rasmussen and Friedman, 2000;
Hugot et al, 2001). In CD, a common chronic inflammatory
disorder of the intestinal tract, nearly 40 variants of the
CARD15 gene have been detected (Hugot et al, 2001).
NOD2, the product of CARD15, is a member of a growing
family of proteins, called NODs (for nucleotide-binding oli-
gomerization domains), that have been implicated in the
regulation of immune responses and cell death in animals
and plants (Girardin et al, 2002; Inohara and Nunez, 2003).
NOD2 acts as a bacterial peptidoglycan (PGN) recognition
molecule through specific detection of the conserved mura-
myl dipeptide (MDP) structure (Bonen et al, 2003;
Chamaillard et al, 2003c; Girardin et al, 2003a; Inohara et al,
2003). Three major CD-associated NOD2 mutations, R702W,
G908R and L1007fsinsC (Hugot et al, 2001; Ogura et al,
2001a), and multiple rare variants (Chamaillard et al,
2003c) have been found to be deficient in their ability to
sense PGN and/or synthetic MDP (Girardin et al, 2003a;
Inohara et al, 2003). Homozygosity and compound hetero-
zygosity increase up to B40-fold the genotype relative risk
for CD compared to simple heterozygosity (B2–4-fold)
(Hampe et al, 2001; Hugot et al, 2001; Ogura et al, 2001a).
The human NOD protein family contains approximately 20
members including NOD1, NOD2, Cryopyrin, Apaf-1 and
CIITA (Inohara and Nunez, 2003). The great majority of
NODs contain an N-terminal effector domain, a centrally
located NOD and C-terminal leucine-rich repeats (LRRs)
(Inohara and Nunez, 2003). NOD1 and NOD2 have one and
two caspase-recruitment domains (CARDs), respectively, as
N-terminal effector domains and activate NF-kB through
interaction with the downstream factor RICK (also called
RIP2 and CARDIAK) (Bertin et al, 1999; Inohara et al, 1999;
Ogura et al, 2001b). Oligomerization of NOD1, and presum-
ably of NOD2, promotes the proximity of RICK molecules and
of the I-kB kinase (IKK) subunits, leading to IKK and NF-kB
activation (Chamaillard et al, 2003a; Inohara and Nunez,
2003). In addition to CD, recurrent missense mutations (i.e.
R334Q-Wand L469F) in the NOD domain of NOD2 have been
associated with Blau syndrome (BS), a monogenic, domi-
nantly inherited disease characterized by early-onset granu-
lomatous arthritis (Miceli-Richard et al, 2001). The BS-
causing mutations exhibit enhanced basal NF-kB activity
compared to wild-type NOD2 (Chamaillard et al, 2003c).
Three other closely related autosomal-dominant diseases,
familial cold autoinflammatory syndrome (FCAS), Muckle–
Wells syndrome (MWS), and chronic infantile neurological
cutaneous and articular syndrome (CINCA), are associated
with missense mutations that localize to the NOD region of
Cryopyrin (Chamaillard et al, 2003a; Inohara and Nunez,
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2003). Moreover, mutations in the LRRs of CIITA are asso-
ciated with type II bare lymphocyte syndrome, indicating an
essential role for the LRRs in CIITA function (Chamaillard
et al, 2003a; Inohara and Nunez, 2003). Similarly, plant NOD
proteins are a class of disease-resistance (R) proteins that
recognize pathogens through their LRRs and induce a signal-
ling response against pathogens (Dangl and Jones, 2001;
Meyers et al, 2003).
In the present study, we generated a comprehensive library
of NOD2 and NOD1 variants to study the molecular basis of
bacteria-induced NF-kB stimulation. In this study, 519 amino-
acid residues of NOD2 were mutated. Functional analyses
revealed mechanisms of NOD2 regulation as well as con-
served and nonconserved mechanisms whereby NOD1 and
NOD2 mediate the recognition of PGN.
Results
Construction of a library of NOD2 mutants
To define amino-acid residues that are important for NOD2
function and disease susceptibility, we designed an approach
to introduce systematically point mutations in the entire
coding region of CARD15/NOD2 at a controlled rate by
polymerase chain reactions (Shafikhani et al, 1997). The
approach combines random mutagenesis and systematic
functional analysis of each generated mutant clones.
Because NOD2 is composed of 1040 amino acids, the mutants
were constructed with four different cassettes separated by
unique restriction sites (Figure 1A). Under our experimental
conditions, the mutant library for each cassette contained an
average of three nucleotide substitutions per 1000 base pairs
(range 1–7) resulting in B2 amino-acid substitutions per
cassette (data not shown). In total, 806 nucleotide substitu-
tions in the coding region were analyzed resulting in 519
amino-acid changes (B50% of the NOD2 residues;
Figure 1B). Our present study involved 338 independent
clones of which 148 contained single amino-acid substitu-
tions and 190 contained multiple (range 2–5) amino-acid
replacements in NOD2. A summary of all NOD2 mutant
clones including the type of mutation, location of the muta-
tion and in vitro functional activity is shown in Figure 1B. The
ability of each mutant to induce MDP-dependent and -inde-
pendent activation of NF-kB was determined using a lucifer-
ase reporter NF-kB assay (Inohara et al, 2001; Ogura et al,
2001b). Briefly, mutant and wild-type NOD2 clones were
transiently expressed in HEK293T cells in the presence or
absence of MDP. The analysis was primarily based on the 127
clones with single missense mutations and the 59 clones with
nonsense and frameshift mutations. However, the results of
all generated clones are provided in Supplementary Tables 1,
2 and 3.
CARDs of NOD2 in RICK-dependent NF-jB activation
We mutated B57% (127/220) of the amino acids in the
CARDs of NOD2 (Figure 1B and Supplementary Table 1).
The analysis included 14 mutants with only one amino-acid
substitution in the CARDs of NOD2, of which seven (Q31H,
E69K, T91I, A106V, L145P, P177S and R180K) exhibited
complete loss and/or greatly reduced activity in response to
MDP (Supplementary Table 1 and Figure 2B), indicating that
these CARD residues are essential for NF-kB activation.
Representative results from a mutant clone with wild-type
phenotype (M152L) and loss-of-function mutants with single
amino-acid replacements in CARD1 (Q31H, E69K and A106V)
or CARD2 (L145P and R180K) are shown in Figure 2B and/or
in Supplementary Table 1. Immunoblotting analysis revealed
that most of the loss-of-function mutants were expressed at
levels similar to those of the wild-type protein (Figure 2C and
Supplementary Table 1). However, some of the CARD point
mutants including F161I, P177S and R180K were not ex-
pressed, suggesting that these mutations are associated
Figure 1 Strategy for NOD2 mutagenesis and summary of studied NOD2 mutations. (A) Schematic representation of NOD2 including
mutagenized cassettes (I–IV). The location of CARDs, NOD domain and leucine-rich repeat domain (LRD) are shown. Numbers represent the
position of amino-acid residues. Restriction enzyme sites flanking each cassette are shown. (B) Summary of NOD2 mutations generated and
analyzed. WT, wild-type; ND, not determined.
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with reduced protein stability (Figure 2C and Supplementary
Table 1).
NOD2 associates with its downstream effector RICK
through a homophilic CARD–CARD interaction to activate
NF-kB (Ogura et al, 2001b). To determine whether the CARD
mutants interact with RICK, we carried out immunoprecipita-
tion experiments in which NOD2 and RICK proteins
were transiently coexpressed in HEK293T cells. Immuno-
precipitation analyses revealed that RICK interacted with
T91I and Q204R, a control mutant with wild-type phenotype,
as effectively as with wild-type NOD2 molecule (Figure 2E).
In contrast, the loss-of-function NOD2 mutants, Q31H, A106V
and L145P, exhibited reduced association with RICK
(Figure 2C). As expected, the F161I mutant, which displayed
greatly reduced expression, did not immunoprecipitate with
RICK (Figure 2C). RICK has been found to be phosphorylated
when overexpressed in mammalian cells (Ogura et al, 2001b),
although the physiological role of phosphorylated RICK re-
mains unclear. Notably, the NOD2 mutants with impaired
ability to interact with RICK did not induce the mobility
shift associated with RICK phosphorylation (Figure 2C),
indicating that RICK phosphorylation correlates with the
ability of NOD2 to interact with RICK and with the activation
of NF-kB.
A dominant-negative mutant of NOD2 signalling
The interaction between NOD2 and RICK appears essential
for NF-kB activation (Ogura et al, 2001b). Therefore, we
tested if the loss-of-function CARD mutants could inhibit
the activity induced through the NOD2 signalling pathway.
The analysis revealed that L145P, a CARD2 mutant, but not
A106V, Q31H nor F161I, inhibited the ability of RICK to
activate NF-kB (Figure 2D). Moreover, L145P, but not mu-
tants lacking one or two CARDs, inhibited the ability of wild-
type NOD2 to activate NF-kB in the absence or presence of
bacterial components (Figure 2E). HEK293T cells express
a low level of endogenous NOD2 and activate NF-kB in
response to a high concentration of MDP (5 mg/ml)
(Supplementary Table 2). To determine whether the L145P
mutant could inhibit the activity of endogenous NOD2, we
transfected HEK293T cells with constructs expressing the
L145P mutant or dominant-negative forms of TBK1 and
Figure 2 Mutational analyses of the CARD of NOD2. (A) Schematic representation of the N-terminus region of NOD2. Numbers indicate the
position of amino-acid residues. Loss-of-function mutations are shown in black. Clones with wild-type activity are depicted in gray and
mutations found in complex mutant clones (i.e. more than one amino-acid substitution) with wild-type activity are shown in gray italic.
Mutations associated with reduced expression are labelled with the symbol a. Mutations found in Crohn’s patients are labelled with the symbol
b. (B) NF-kB activity of representative CARD mutants. E778K and DLRR are shown as controls. Values represent the mean of normalized
data7s.d. of triplicate cultures. (C) Interaction of NOD2 mutants with RICK. Extracts from HEK293T cells expressing indicated mutants were
immunoprecipitated with anti-Myc antibody and immunoblotted with anti-NOD2 antibody. IP, immunoprecipitation; total, immunoblotting of
total lysates. A black dot denotes the mobility shift of the phosphorylated form of RICK. (D) Inhibition of RICK-induced NF-kB activation by
CARD mutants and PEA15 control plasmid. Values represent the mean of normalized data7s.d. of triplicate cultures. (E) Specific inhibition of
MDP-induced NOD2-mediated NF-kB by the L145P mutant. An LPS preparation containing MDP-like activity (closed bars) was used in this
assay. (F) Inhibition of MDP-induced NF-kB activation by the L145P mutant and dominant-negative form of IKKg in HEK293Tcells. DN denotes
dominant-negative form.
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MyD88 (as negative controls) or IKKg as a positive control
and stimulated the cells with MDP. We found that the L145P
mutant, like a dominant-negative form of IKKg, exhibited a
dominant-negative effect on NOD2-mediated signalling,
whereas interfering mutants of TBK or MyD88 did not
(Figure 2F). These results indicate that the dominant-negative
effect of the mutation L145P is specific.
Critical residues in the NOD domain required for
bacterial recognition
This work included missense mutants with substitutions in
249 amino-acid residues of the NOD domain (Figures 1B and
3A). The analysis of the generated mutant clones was pri-
marily restricted to the 59 mutants with a single amino-acid
substitution. Initial functional screening of these mutants
using synthetic MDP revealed 21 residues in the NOD domain
that are critical for NOD2 function (Figure 3A). These in-
cluded mutation of the conserved Asp residue at position 379,
D379A, in the Walker’s B box (Figure 3B), which is essential
for binding to the Mg2þ -substrate and nucleotide hydrolysis
(Walker et al, 1982). The D379A NOD2 mutant did not
respond to MDP (Supplementary Table 1), suggesting that
nucleotide hydrolysis is essential for MDP-dependent NF-kB
activation. The equivalent mutation of D284A in NOD1 as
well as the K208R mutation in the A box of NOD1 resulted in
loss of ligand-dependent NF-kB activation (Supplementary
Table 2). Thus, the requirement of the B box for the response
to bacterial components is conserved between NOD1 and
NOD2. In addition, mutation of amino-acid residues A232,
V295, F327, C333, S344, S396, T401, F408, A429, V492, L626,
P639, K655, G680, L690, A691, S714 and H734, located within
the NOD domain, resulted in loss of MDP-dependent NF-kB
activation (Figure 3B). Similarly to D284A, most of these
NOD mutants retained their ability to activate NF-kB
when overexpressed in HEK293T cells (Figure 3B and
Supplementary Table 1). Immunoblotting analysis showed
appropriate expression of the mutants except for C333Y and
A232P whose expression was undetectable (Figure 3B), sug-
gesting that the latter residues are important for protein
stability.
Distinct functional alteration of NOD2 variants
associated with BS and CD
Several missense NOD2 mutants in NOD were identified that
are found at a low frequency (i.e. less than 1%) in Western
European populations (Hugot et al, 2001; Lesage et al, 2002).
Seven of these natural mutations, A140T, R373C, S431L,
V793M, N853S, V955I and G978E, were generated through
random mutagenesis of NOD2. In addition, we engineered
R334W and R334Q, two recurrent BS-causing mutations.
Figure 3 Mutational analyses of the NOD domain of NOD2. (A) Schematic representation of the NOD domain. The Walker’s A and B boxes are
depicted by solid dots. Numbers indicate the position of amino-acid residues. Symbols and color code are described in Figure 2. The gain-of-
function mutations are labelled with the symbol c. (B) NF-kB activity of representative NOD domain mutants in the presence or absence of
MDP. E778K and DLRR are shown as controls. Expression of NOD2 proteins is shown on top. (C) Interaction of NOD2 mutants with RICK.
Extracts from HEK293Tcells expressing indicated mutants were co-immunoprecipitated with anti-Myc antibody and immunoblotted with anti-
NOD2 antibody. IP, immunoprecipitation; total, immunoblotting of total lysates. A black dot denotes phosphorylated form of RICK. (D)
Evidence of intramolecular interaction between the C-terminal region of the NOD domain and proximal LRRs by functional complementation.
NF-kB activity in the presence or absence of MDP is shown for NOD2 mutant and wild-type clones. Values represent the mean of normalized
data7s.d. of triplicate cultures.
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Consistent with a recent report (Chamaillard et al, 2003c),
both R334W and R334Q exhibited increased basal NF-kB
activity, which was comparable to that observed with
NOD2 lacking the LRRs (Figure 3B). Unlike the DLRR
NOD2 mutant, the NF-kB activity of R334W and R334Q was
further enhanced by addition of MDP (Figure 3B). Thus, the
BS-associated R334W and R334Q variants function as hyper-
responsive mutations. To determine whether the two BS-
causing mutations (R334W and R334Q) and loss-of function
mutants (D379A and E778K) could exhibit abnormal interac-
tion with RICK, we coexpressed the NOD2 mutants or V295M
(a mutant with wild-type phenotype) and Myc-tagged RICK
and immunoprecipitated the cell lysates with anti-Myc anti-
body. Immunoprecipitation analyses showed that the activity
of the mutants cannot be explained by an altered interaction
with RICK (Figure 3C).
A novel regulatory region of NOD2
Multiple mutations (i.e. frameshift and nonsense mutations)
resulted in premature C-terminal truncation of NOD2
(Figure 4). Truncation at the first or second CARD of NOD2
resulted in mutations that were unable to activate NF-kB
(Figure 4). This is consistent with the observation that both
CARDs of NOD2 are required for association with RICK, an
essential downstream factor for NOD2 activity (Ogura et al,
2001b; Kobayashi et al, 2002). Truncation at the most C-
terminal LRRs (residues 855-1040) of NOD2 resulted in
mutants that were able to activate NF-kB at a level compar-
able to that of the wild-type protein, but were unresponsive to
bacterial components (Figure 4 and Supplementary Table 1).
Notably, sequential truncation from residue 664 to 854
resulted in NOD2 mutants with elevated basal NF-kB activity
(Figures 4 and 5A and Supplementary Table 1). Additional
truncation N-terminal to residue 664 or C-terminal to residue
855 (located in the fifth LRR) resulted in loss of the consti-
tutive ability of NOD2 to activate NF-kB (Figures 4 and 5A).
Immunoblotting analysis revealed that the expression levels
of the truncated NOD2 mutants could not explain the ob-
served differences in NF-kB activity (Figure 5B). These
results indicate that the borders of the regulatory region are
located between residues 664 and 854. Furthermore, the
region from residue 855 to the C-terminus, which expands
from the distal part of the fifth LRR to the 11th LRR, is
sufficient to suppress the constitutive activation of NOD2.
To test whether the mechanism of activation is conserved
between NOD1 and NOD2, we generated a panel of NOD1
mutants and tested their ability to induce NF-kB in the
presence or absence of a commercial lipopolysaccharide
(LPS) preparation from Escherichia coli O55:B5, with traces
of PGN-derived g-D-glutamyl-meso-diaminopimelic acid (iE-
DAP), the moiety recognized by NOD1 (Chamaillard et al,
2003b; Girardin et al, 2003b). These experiments revealed
that truncation of NOD1 from residues at positions 648 and
668 yielded mutants with enhanced basal NF-kB activity but
unresponsive to the LPS preparation (Figure 5C and
Supplementary Table 2). These results indicate that the distal
LRRs of both NOD1 and NOD2 are essential for suppression
of the constitutive activation of these proteins as well as for
recognition of bacterial components (Figure 4 and below).
The analysis uncovered three loss-of-function mutants
within the regulatory region that could be rescued in cis by
mutations within the proximal LRRs. For example, G680W
Figure 4 Analysis of truncated NOD2 mutants. The location of CARDs, NOD domain and LRD are shown. The Walker’s A and B boxes in the
NOD domain are depicted by solid dots. The basal NF-kB activity (BNA) and NF-kB response to bacterial components (BR) are shown. þ ,
response similar to that obtained with the wild-type protein; , no response above control plasmid; þ þ þ , response at least three-fold greater
than that obtained with wild-type NOD2. Representative results are shown in Figure 3. Numbers represent the position of amino-acid residues.
The names of individual mutations are shown on the left. WT, wild-type clone.
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was a loss-of function mutant in that it failed to respond to
MDP (Figure 3D). Yet, the double G680W/G761S, as the
single G761S, was fully competent to be activated by MDP
(Figure 3D). Similarly, the point mutant G775D functioned as
a loss-of-function mutant, whereas the A725T/A726T and
G775D/A725T/A726T mutants responded normally to MDP
(Supplementary Table 2). Similar complementation was ob-
served with two additional loss-of-function mutants G680R
and C779Y in that the triple G680R/C779Y/N872K exhibited a
normal response to MDP (Supplementary Table 1). These
results reveal functional interactions between residues lo-
cated in the C-terminal region of the NOD domain and the
proximal LRRs.
Missense mutations in the C-terminal region of the NOD
domain can exhibit constitutive NF-jB activity
We identified several missense mutations within the inhibi-
tory domain described above (P668H, I673F, G680R/C710Y,
F719I/K731R and N637I/A725V) that exhibited constitutive
NF-kB activity (Figure 5E and Supplementary Table 1). Unlike
the BS-associated mutations, the increased basal activity of
these mutants was not further enhanced by MDP (Figure 5C).
The G680R mutation by itself is a loss-of-function mutation,
but the G680R/C710Y mutant clone is a gain-of-function
mutant, suggesting intramolecular interactions within the
regulatory region (Supplementary Table 1). P668H and
I673F represent mutants with single amino-acid substitu-
tions. Significantly, we identified a point mutant, L620Q, in
the corresponding region of NOD1 that also exhibited con-
stitutive NF-kB activity (Supplementary Table 2), suggesting
a conserved mechanism of NF-kB activation regulation.
Amino-acid alignment of NOD2, Cryopyrin and related
NOD family members revealed that I673 in NOD2 corre-
sponds to amino-acid residue F573 in Cryopyrin
(Supplementary Figure 1). Notably, an F573S mutation in
Cryopyrin causes the autoinflammatory disorder CINCA
(Hull et al, 2003). Thus, F573S may represent a constitutively
active mutation of Cryopyrin leading to clinical disease.
Amino-acid residues in the LRR predicted to be solvent
exposed are essential for bacterial recognition
The analysis included 50 LRR mutants involving single
amino-acid residues (Figure 1B and Supplementary Table 1).
Functional analysis revealed that 20 out of the 50 mutants
were unable to respond to MDP (Figure 6 and Supplementary
Table 1). In contrast, multiple LRR mutants including A759V,
G761S, L762M, V793M, I805N, P812T, D824N, A860G, L876I,
Q889P, L891M, A892V, L904M, D913V, A920T, A944V, L947M,
L949M, M956T, Q968H, G978E, S984T, K986I, A1002S,
T1012I/S, G1032C and L1038F exhibited a wild-type pheno-
type (Figure 6 and Supplementary Table 1). Three-dimen-
sional molecular modelling using the structure of the
placental ribonuclease inhibitor (Papageorgiou et al, 1997)
revealed that the loss-of-function mutations E751K, G775D,
E778K,C779Y, D829Y, G831D, T844I, V890A, T899A, D913E,
G915E, G999R and N1010S are predicted to be located in the
turn regions and a-helices of the LRRs (Figure 7C). In con-
trast, the loss-of-function mutations G879R, W907L, V935M,
E959K, C961Y, K986I, K989E and S991F involve amino-acid
residues that are predicted to form b-strands that constitute
Figure 5 Analyses of truncated mutants reveal an inhibitory domain in NOD1 and NOD2. (A) NOD2 activity in the absence (open bars) and
presence of LPS preparation (closed bars). A schematic diagram of part of NOD and LRD of NOD2 is shown. Numbers indicate the position
(amino-acid residue) of C-terminal truncations. WT, wild-type. E778K represents a control loss-of-function mutant. () represents results
obtained with control plasmid. (B) Immunoblotting analysis of NOD2 mutants. Analysis was performed with cell extracts from HEK293T cells
transfected with indicated mutant or wild-type NOD2 plasmid or control plasmid () and immunoblotted with anti-FLAG antibody. (C) NF-kB
activity of NOD domain gain-of-function mutants in the presence or absence of MDP. Wild-type (WT) and mock cells () are shown as
controls. Values represent the mean of normalized data7s.d. of triplicate cultures. (D) NOD1 activity in the absence (open bars) and presence
of LPS preparation (closed bars). A schematic diagram of part of NOD and LRD of NOD1 is shown. Numbers indicate the position (amino-acid
residue) of C-terminal truncation. WT, wild-type. (E) Immunoblotting analysis of NOD1 proteins. The analysis was performed with cell extracts
from HEK293T cells transfected with indicated mutant and wild-type NOD1 plasmids or control plasmid () and immunoblotted with anti-
NOD1 antibody.
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the concave face of the LRRs (Figure 7D). Notably, all these
amino-acid residues reside in LRR6–LRR11, indicating that
the most C-terminal LRRs of NOD2 are critical for bacterial
recognition. More specifically, these residues are confined to
the b-strand/b-turn (xxLxLxx) motif (Kajava and Kobe,
2002). Amino acids G879, W907, V935, E959, K989 and
S991 are variable in that they are not conserved in the
corresponding regions of LRR proteins and are predicted to
Figure 6 Mutational analyses of the LRRs of NOD2. NF-kB activity of LRR mutants in response to MDP. Values represent the mean of
normalized data7s.d. of triplicate cultures. Expression of NOD2 proteins is shown at the bottom.
Figure 7 Computer-assisted molecular modelling of the LRRs of NOD2. (A) The predicted structure of the 11 LRRs of NOD2. (B) Location of
amino-acid residues mutagenized. (C) Position of loss-of-function NOD2 mutants with single amino-acid substitutions in the LRRs. Mutations
located in a-helix/turn regions and b-strands are depicted in white and yellow, respectively. The E778K, E843K and G908R mutants
(underlined) have been found in CD patients. (D) Amino-acid alignment of the turn region and b-strands of LRRs of NOD2. Letters denote
amino-acid residue. X denotes any amino acid. The locations of residues involved in amino-acid substitutions with wild-type and loss-
of-function phenotype are shown in green and yellow, respectively. The specific amino-acid replacements are shown in Figure 6 and
Supplementary Table 1.
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face outward (Figure 7D). These nonconserved residues
correspond to those known to mediate the interaction of
other LRR proteins with their binding partners (Kobe and
Deisenhofer, 1995; Papageorgiou et al, 1997; Price et al,
1998). These results suggest that the residues G879, W907,
V935, E959, K989 and S991 might be involved in MDP
binding and/or protein–protein interactions required for
MDP recognition.
Comparison between the LRRs of NOD1 and NOD2
We generated 31 missense mutants by random mutagenesis
involving the LRRs of NOD1. Eight residues were essential
and 23 were dispensable for the response to the LPS prepara-
tion containing NOD1-stimulatoty activity (Supplementary
Tables 2 and 3). To determine whether the residues required
for recognition of bacterial components are conserved, we
compared the activity of NOD1 and NOD2 mutants with
homologous amino-acid substitutions at the same LRR posi-
tions. The comparison revealed that one pair of mutated
residues exhibited impaired recognition of bacterial compo-
nents (D691V and E778K in NOD1 and NOD2, respectively),
four pairs had wild-type activity in both NOD1 and NOD2,
and two pairs of homologous residues (G857R and A944V,
and K989E and W902G, in NOD1 and NOD2, respectively)
exhibited discordant phenotype in that the mutations im-
paired NOD2 but not NOD1 function. Notably, E778K is a
loss-of-function NOD2 mutation found in CD patients (Hugot
et al, 2001). These results suggest that conserved and non-
conserved structures in the LRRs of NOD1 and NOD2 mediate
the recognition of bacterial PGN motifs. As it was found in
NOD2, several residues in the proximal LRRs of NOD1 (D691,
L715 and N738) were essential for PGN recognition
(Supplementary Table 3).
Discussion
In this report, we describe a systematic mutational strategy to
get an insight into the molecular function of NOD2 and the
mechanism of disease susceptibility. In the present study, we
identified multiple residues in the LRRs that are essential for
bacterial recognition. Several mutations deficient in MDP
recognition (E751K, G775D, E778K, C779Y, D829Y, G831D,
T884I, V890A, V911M, D913E, G915E, L960V, G999R and
N1010S) involved residues predicted to be located in the a-
helix/turn regions that form the convex face of the LRRs. The
role of the a-helix/turn LRR residues in MDP recognition is
unclear. They may be involved in protein folding or intramo-
lecular interactions between the NOD and LRR domains or
between the different LRRs rendering NOD2 competent for
MDP recognition. Alternatively, these residues may be in-
volved in interactions with MDP directly or indirectly through
cellular factors. We favor the first two possibilities because
structural and genetic analyses have implicated b-strands
rather than the a-helical regions of the LRRs in ligand
interactions (see below). Notably, the loss-of-function muta-
tions E778K and E843K (Chamaillard et al, 2003c) are pre-
dicted to alter the a-helix/turn LRR structure (Figure 7) and
have been found only in CD patients, suggesting a potential
molecular mechanism leading to CD. Several amino acids
located in the concave face of LRR7–LRR11 were found to be
essential for MDP recognition. These amino acids, G879,
T899, W907, V935, E959, K989 and S991, are predicted to
form a b-strand/b-turn structure based on molecular compar-
isons of the LRRs of NOD2 with those of the human and
porcine ribonuclease inhibitor proteins (Kajava and Kobe,
2002). Three-dimensional analyses of ribonuclease inhibitor
proteins in complex with their targets revealed that LRR
residues corresponding to G879, W907, G908, V935, E959,
K989 and S991 within the LRRs of NOD2 are predicted to be
exposed to solvent and mediate interactions with their pro-
tein partners (Kobe and Deisenhofer, 1995; Papageorgiou et al,
1997).
In plant NBS-LRR proteins, the LRR is the most variable
region and is under diversifying selection driven by patho-
gens (Dangl and Jones, 2001). Within the LRRs of plant R
proteins, most variation occurs within variable residues pre-
dicted to form the b-strand/b-turn structure of the LRRs
(Dangl and Jones, 2001). Analyses of chimeric genes have
revealed that the nonconserved residues confined to the b-
strand/b-turn structure determine pathogen recognition and
specificity of R genes (Dodds et al, 2001). Our studies suggest
a shared molecular mechanism between animals and plants
for intracellular pathogen recognition. A possible interpreta-
tion is that MDP interacts directly with the LRRs and more
specifically with the b-strand/b-turn structure of the LRR6–11
of NOD2. Alternatively, NOD2 may require host cofactors to
interact with MDP. It is also formally possible that these LRR
residues are involved in some other function that is indirectly
required for MDP recognition.
The present study has revealed a region encompassing the
C-terminal region of the NOD domain and proximal LRRs that
mediate inhibition of NOD2 activity. A similar inhibitory
region has been identified in plant NBS-LRR proteins
(Bendahmane et al, 2002; Shirano et al, 2002; Zhang et al,
2003). NOD1 also contains a similar region capable of
repressing its basal NF-kB activity, suggesting a conserved
downregulatory mechanism in plants and mammalian NOD
family members. The regulatory function might be mediated
through intramolecular interactions between the inhibitory
region and sequences in the CARDs and/or the NOD domain.
Such interaction(s) will be predicted to inhibit the activity of
NOD2 in that the CARDs and NOD domain are essential for
MDP-dependent NF-kB activation. Consistent with this
model, there is evidence for intramolecular interactions in-
cluding the LRR with the N-terminal region of the NOD
domain in plant NBS-LRR proteins (Hwang et al, 2000;
Moffett et al, 2002; Hwang and Williamson, 2003). Thus,
the regulatory region of NOD2 may mediate an inhibitory
function to retain the protein in an inert conformation in the
absence of bacterial products. Alternatively, the regulatory
region may mediate activation that is repressed by the C-
terminal flanked LRRs. We identified functional complemen-
tation between amino-acid residues located in the first and
second LRRs and the C-terminal region of the NOD domain.
A possibility is that the proximal LRRs suppress NOD2
activation through the C-terminal region of the NOD domain.
Upon exposure to MDP, the inhibition of NOD2 mediated by
the proximal LRRs may be relieved leading to signalling
through NOD oligomerization and recruitment of RICK.
We identified several point mutations located in the reg-
ulatory region and specifically within the C-terminal region of
the NOD domain that exhibit constitutive activity. These
NOD2 mutations appear to be related to signalling and/or
regulation rather than recognition in that they activated
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NF-kB in an MDP-independent manner. This C-terminal
region of NOD corresponds to the previously described ARC
subdomain (van der Biezen and Jones, 1998). Interestingly,
similar gain-of-function mutations located in the ARC sub-
domain and N-terminal LRRs have been described in plant
NBS-LRR proteins (Bendahmane et al, 2002; Shirano et al,
2002; Zhang et al, 2003). These results argue for conservation
of regulatory mechanisms between plant and animal NOD
proteins. Unlike the BS-associated mutations, located within
the regulatory region and the N-terminal NB subdomain, the
activity of these mutants including P668H and I673F was not
further enhanced by MDP. Significantly, the corresponding
residue at position 673 in human Cryopyrin is F573 whose
Ser mutation causes the neonatal autoinflammatory disorder
CINCA (Hull et al, 2003). Thus, Cryopyrin F573S might be a
constitutively active mutant that is compatible with the
dominant mode of transmission of the disease. These two
types of activating mutations may explain, at least in part,
differences in clinical presentation and severity observed
between MWS/FCAS and CINCA. The molecular basis for
the constitutive activation of NOD2 mutations located in the
C-terminal region of the NOD domain is unclear. A possibility
is that they disrupt the repressing function leading to deregu-
lated activation. In such a model, these activating mutations
may mimic recognition of MDP in that the inhibitory activity
exerted by the proximal LRRs may be relieved by the
mutation.
Numerous amino-acid variations have been found in
CARD15 of humans and mice (Hugot et al, 2001; Ogura
et al, 2003). In humans, the great majority of NOD2 variants
are rare in that they are found at a frequency of less than 1%
in healthy and/or CD patients (Hugot et al, 2001; Lesage et al,
2002). Up to 20% of these rare alleles were retrieved in the
present study. These results together with those of a recent
study (Chamaillard et al, 2003c) indicate that rare and
common loss-of-function NOD2 alleles are involved in dis-
ease pathogenesis. Consistent with previous findings
(Chamaillard et al, 2003c), several of the rare CARD15/
NOD2 variants found in CD patients, including A140T,
R373C, V793M and G978E, exhibited wild-type function,
suggesting that they likely represent neutral polymorphisms
without clinical significance (Chamaillard et al, 2003a).
Several amino-acid residues in the CARDs of NOD2 were
essential for NF-kB activation. The loss of activity of most of
the CARD mutants could be explained, at least in part, by
their decreased ability to associate with RICK. Three rare CD-
associated NOD2 missense mutations were found to exhibit a
loss-of function phenotype (Chamaillard et al, 2003c). The
residues involved in these CD mutations are located in the
a-helices of the CARDs, suggesting that these mutants may
exhibit impaired binding to RICK. L145P, a loss-of-function
CARD2 mutant, functioned as a dominant negative of NOD2
signalling. Three CD-associated NOD2 mutants were reported
to act as dominant negative (Chamaillard et al, 2003c). The
mechanism of inhibition mediated by L149P and the CD-
associated mutations remains to be elucidated. These mutant
proteins may act by interfering with the recruitment of active
RICK complexes, NOD2 oligomerization and/or by seques-
trating another factor required for downstream signalling.
The NOD2 variants associated with BS, R334W and R334Q
exhibited increased basal NF-kB activity and enhanced re-
sponse to bacterial components. This is in contrast to NOD2
mutations associated with CD, which display defective re-
cognition of MDP (Bonen et al, 2003; Chamaillard et al,
2003c; Girardin et al, 2003a; Inohara et al, 2003). The
centrally located NOD in plant/animal proteins corresponds
to the NB-ARC domain that includes the NB and ARC sub-
domains (van der Biezen and Jones, 1998). These BS-asso-
ciated mutants were located in the N-terminal region of the
NOD domain or NB subdomain (van der Biezen and Jones,
1998). The difference in functional activity displayed by
NOD2 mutations associated with CD and BS is consistent
with the distinct mode of genetic transmission of these
NOD2-associated diseases and could explain the clinical
differences observed between these two disorders
(Chamaillard et al, 2003a). Significantly, the R334Wmutation
in NOD2 corresponds to the R260W Cryopyrin mutation,
which is known to cause the inflammatory disorders
MWS and FCAS (Chamaillard et al, 2003c). Thus, BS and
MWS/FCAS may share a common deregulated molecular
mechanism.
Almost all residues whose mutation resulted in loss of
function are conserved in both human and mouse NOD2
(Ogura et al, 2003) (Supplementary Table 1). However, sub-
stitution of Pro for Ser at position 177 in the CARDs of human
NOD2 resulted in loss of function (Figure 4A). Notably, the
corresponding residue at position 177 in mouse NOD2 is Ser
(Ogura et al, 2003). Moreover, the W130R loss-of-function
mutation is found in CD patients (Chamaillard et al, 2003c)
but mouse NOD2 contains a Trp at the same position (Ogura
et al, 2003). Similarly, P639S and K665E mutations result in
loss of function in human NOD2, but puffer fish and zebra-
fish NOD2 carry Ser and Glu at these positions, respectively
(Ogura et al, 2003). These observations reveal conserved and
nonconserved structures in human NOD2 and suggest poten-
tial pitfalls when deciphering protein function based solely on
conservation of amino-acid residues. The identification of
residues acting in cis to alter the activity of mutant NOD2
highlights the importance of considering mutant combina-
tions when performing functional and genetic analyses of
disease-associated proteins.
The current work represents an exhaustive mutational
analysis of NOD2, in that 519 out of the 1040 amino acids
of NOD2 were mutated. Individual analysis of certain mutant
proteins should be interpreted with caution in that some
negative results are noninformative due to the potential
misfolding of the mutant protein. In addition to providing
insights into the molecular function of NOD2, up to 20% of
the genetic variants found at rare frequency in CD patients
were recovered in the current analysis. A similar approach
could be used to analyze any disease-associated protein in




LPS from E. coli O55:B5 and MDP were obtained from Sigma-
Aldrich (St Louis, MO). The source of LPS from Campylobacter
jejuni was described (Inohara et al, 2001). iE-DAP was synthesized
as described previously (Chamaillard et al, 2003b).
Mutagenesis of NOD1 and NOD2
The strategy to perform random mutagenesis of NOD2 is described
in the Results section. Each cassette containing the coding region of
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NOD2 was mutagenized using the GeneMorph PCR kit (Stratagene,
La Jolla, CA), which is based on the use of an error-prone DNA
polymerase and reaction conditions that allow the generation of
mutations at a controlled rate (Shafikhani et al, 1997). Each primer
was designed to contain restriction sites so that each PCR product
was digested with appropriate restriction enzymes and inserted in-
frame into the remainder of the coding region of NOD2 (see
Figure 1B). A nucleotide cassette encoding the C-terminal region of
NOD1 (amino-acid residues 605–953) was similarly mutagenized
using the GeneMorph PCR kit. The entire coding sequence of NOD1
and NOD2 clones was verified by direct DNA sequencing.
Expression plasmids producing E778K and BS-associated NOD2
mutants, R334Wand R334Q, were generated by the QuikChange XL
site-directed mutagenesis kit (Stratagene, La Jolla, CA). The
authenticities of the constructs were confirmed by DNA sequencing.
Transfection and NF-jB activation assay
HEK293T cells were transfected with reporter plasmids (7.3 ng
pBxIV-luc and 73ng pEF-BOS-b-gal/well) plus control plasmid ()
or pcDNA3-NOD1-FLAG (0.3 ng/well) or pcDNA3-NOD2 (0.1 ng/
well) as described previously (Inohara et al, 2001). Plasmids
expressing dominant-negative forms of TBK1, MyD88 or IKKg have
been reported (Inohara et al, 2003). The NOD2 mutants, DCARD1,
DCARD2 and DCARDs, have been described (Ogura et al, 2001b).
NF-kB activation assays with HEK293T cells were performed as
described (Inohara et al, 2003). LPS (1mg/ml) and MDP (10ng/ml)
were added to the cultures 8 h post-transfection in the presence of
calcium phosphate to allow their entry into the cells as reported
(Inohara et al, 2003). All NOD2 mutant clones were tested for their
response to synthetic MDP except truncation mutants (Figure 4),
which were stimulated with an LPS preparation known to contain
PGN fragments stimulatory of NOD2 (Bonen et al, 2003; Chamail-
lard et al, 2003c; Girardin et al, 2003a; Inohara et al, 2003).
To assess iE-DAP- and MDP-independent NF-kB activation,
HEK293T cells were transfected as described above except that
100 ng of NOD1 or NOD2 plasmid, respectively, was used (referred
as overexpression studies). At 24 h post-transfection, NF-kB-
dependent transcription was determined (Inohara et al, 2003).
Results were normalized for transfection efficiency with values
obtained with pEF-BOS-b-gal.
Immunoprecipitations and immunoblotting
HEK293Tcells were harvested 24h following transfection and lysed
in 0.2% Nonidet P-40 lysis buffer (Inohara et al, 2001). Immuno-
precipitations were carried out using monoclonal anti-HA antibody
(Roche, IN) to immunoprecipitate RICK protein complexes. The
products were then resolved by 12% SDS–PAGE, and detected by
immunoblotting with rabbit anti-NOD2 (Ogura et al, 2001b) or
rabbit anti-HA antibody to detect RICK (Santa Cruz, CA). Total
lysates were similarly analyzed by immunoblotting with rabbit anti-
NOD1 or anti-NOD2. Polyclonal anti-NOD1 antibody was generated
by immunization of rabbits with recombinant human NOD1 (amino
acids 1–216). A reference extract from HEK293T cells transfected
with the wild-type NOD2 cDNAwas included in all immunoblotting
experiments to compare the expression of mutant and wild-type
proteins.
Bioinformatics
Alignment of LRRs of NOD2 was performed using the program O
with U2A0 (PDB 1A9N) and coordinates of ribonuclease inhibitor
(PDB 1DFJ) as templates. After slight manual adjustment,
coordinates were energy minimized using CNS (Brunger et al,
1998).
Supplementary data
Supplementary data are available at The EMBO Journal Online.
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